Medical Marijuana Research Act
Latest action · Apr 5, 2022 Received in the Senate.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedOct 21, 2021
- Passed HouseApr 4, 2022
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Medical Marijuana Research Act
This bill establishes a new, separate registration process to facilitate medical marijuana research.
Specifically, it directs the Drug Enforcement Administration to register (1) practitioners to conduct medical marijuana research, and (2) manufacturers and distributors to supply marijuana for such research.
Additionally, the Department of Health and Human Services must continue to produce marijuana through the National Institute on Drug Abuse Drug Supply Program and implement a specialized process for supplying marijuana products available through state-authorized marijuana programs to researchers until manufacturers and distributors can provide a sufficient supply of marijuana for medical research.
Recorded votes 1
Newest first. Open one to see how every member voted.
| Roll call | Question | Result | Date |
|---|---|---|---|
| House 108 | On Motion to Suspend the Rules and Pass, as Amended | Passed343–75 | Apr 4, 2022 |
Cosponsors 11
Members who signed on, in the order they did. Signatures ran from Oct 21, 2021 to Apr 4, 2022; 7 are original cosponsors, there from the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| R-MD | Andy Harris | Original | Oct 21, 2021 |
| D-CA | Barbara Lee | Original | Oct 21, 2021 |
| D-MI | Debbie Dingell | Original | Oct 21, 2021 |
| D-HI | Ed Case | Original | Oct 21, 2021 |
| D-DC | Eleanor Holmes Norton | Original | Oct 21, 2021 |
| R-VA | H. Morgan Griffith | Original | Oct 21, 2021 |
| D-TN | Steve Cohen | Original | Oct 21, 2021 |
| R-OH | David P. Joyce | Feb 4, 2022 | |
| D-NH | Chris Pappas | Mar 30, 2022 | |
| D-CO | Ed Perlmutter | Apr 4, 2022 | |
| R-SC | Nancy Mace | Apr 4, 2022 |
Committees 3
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| House | Energy and Commerce Committee | Referred Oct 21, 2021 |
| Health Subcommittee | Referred Oct 22, 2021 | |
| House | Judiciary Committee | Referred Oct 21, 2021 |
| House | Budget Committee | Referred Oct 21, 2021 |
Actions 12
Everything that happened, newest first.
- Apr 5, 2022Received in the Senate.
- Apr 4, 2022Mr. Pallone moved to suspend the rules and pass the bill, as amended.
- Apr 4, 2022Considered under suspension of the rules. (consideration: CR H4136-4140)
- Apr 4, 2022DEBATE - The House proceeded with forty minutes of debate on H.R. 5657.
- Apr 4, 2022At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
In the Congressional Record 2
Days the Record’s own index lists this bill, newest first, with the pages and the members it names. Pages starting H are the House, S the Senate, E Extensions of Remarks.
| Where | In the Record | Members | Date |
|---|---|---|---|
| House | Debate and remarks H4136–H4140Text printed H4136–H4138Recorded votes H4144enactLists H4144Votes recorded by proxy on H.R. 5657, Medical Marijuana Research ActNotices H4152Estimated budget effects of H.R. 5657, Medical Marijuana Research Act | Andy Harris R-MD, Debbie Dingell D-MI, Frank Pallone, Jr. D-NJ, H. Morgan Griffith R-VA, John A. Yarmuth D-KY, Sheila Jackson Lee D-TX | Apr 4, 2022 |
| Extensions | Debate and remarks E1126 | Earl Blumenauer D-OR | Oct 21, 2021 |
Research
What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.
Constitutional authority
The sponsor’s statement, as printed in the Congressional Record, vol. 167, no. 185, October 21, 2021, page H5791.
CRS reports 2
Congressional Research Service work that CRS links to this bill or the law it became, newest first.
Cite it 2
Products on other subjects that cite it, usually among other measures.
| Product | Title | Kind | Published |
|---|---|---|---|
| R45948 | The Controlled Substances Act (CSA): A Legal Overview for the 119th Congress | Report | Jan 22, 2025 |
| R44782 | The Evolution of Marijuana as a Controlled Substance and the Federal-State Policy Gap | Report | Apr 7, 2022 |
Titles 3
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- To amend the Controlled Substances Act to make marijuana accessible for use by qualified marijuana researchers for medical purposes, and for other purposes.
- Short Title(s) as Introduced
- Medical Marijuana Research Act
- Short Title(s) as Passed House
- Medical Marijuana Research Act
Subjects
Assigned by the Library of Congress. Policy area: Health.
- Administrative law and regulatory procedures
- Alternative treatments
- Department of Health and Human Services
- Drug safety, medical device, and laboratory regulation
- Drug therapy
- Drug trafficking and controlled substances
- Food and Drug Administration (FDA)
- Health
- Health personnel
- Licensing and registrations
- Medical research
- Research administration and funding
Text 3
Each version as it was printed, newest first.
- Apr 5, 2022Received in Senate
- Apr 4, 2022Engrossed in House
- Oct 21, 2021Introduced in House
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.